Correlation Between PDS Biotechnology and Leap Therapeutics
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Leap Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Leap Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Leap Therapeutics, you can compare the effects of market volatilities on PDS Biotechnology and Leap Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Leap Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Leap Therapeutics.
Diversification Opportunities for PDS Biotechnology and Leap Therapeutics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between PDS and Leap is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Leap Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leap Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Leap Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leap Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Leap Therapeutics go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Leap Therapeutics
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 1.17 times more return on investment than Leap Therapeutics. However, PDS Biotechnology is 1.17 times more volatile than Leap Therapeutics. It trades about -0.35 of its potential returns per unit of risk. Leap Therapeutics is currently generating about -0.46 per unit of risk. If you would invest 330.00 in PDS Biotechnology Corp on August 27, 2024 and sell it today you would lose (121.00) from holding PDS Biotechnology Corp or give up 36.67% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Leap Therapeutics
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Leap Therapeutics |
PDS Biotechnology and Leap Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Leap Therapeutics
The main advantage of trading using opposite PDS Biotechnology and Leap Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Leap Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will offset losses from the drop in Leap Therapeutics' long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |